GEA is investing EUR 80 million in the construction of a pharmaceutical technology centre for freeze-drying systems in Elsdorf (North Rhine-Westphalia). Partial approval was granted by the authorities in July 2025. With the new location, GEA is responding to the growing global demand for freeze-drying systems while creating capacity for further growth and technological innovation.
The relocation of the previous operations in Hürth to Elsdorf has now begun. Shortly after the partial handover, the first product chambers, central components for the production of freeze dryers in which the actual drying process takes place, were delivered. The installation of the first freeze dryers at the new location represents an important milestone in the construction of GEA’s new pharmaceutical technology center.
Covering an area of more than 40,000 square metres, the new competence and production centre will primarily be used for the construction of freeze-drying systems, which are used worldwide for the manufacture of injectable drugs such as vaccines. The complete relocation of the production, storage, and laboratory areas as well as the administrative functions will take place in the fourth quarter of 2025.
The ‘Factory of the Future’ in Elsdorf stands for future-proof production processes, consistent digitalisation, and sustainable construction: The photovoltaic system supplies environmentally friendly electricity, waste heat is recycled, and green roof areas promote a pleasant working environment – and a focus on biodiversity.
